Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis

Anjan Chatterjee, Elan D. Louis, Steven Frucht

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Anticonvulsants are frequently used in the treatment of paroxysmal kinesiogenic choreoathetosis (PKC). Although they are often extremely effective in eliminating paroxysmal movements, short- and long-term side-effects may limit their use in young patients. Levetiracetam (Keppra), a novel antiepileptic drug approved for the treatment of partial seizures is well tolerated in patients with epilepsy. We report on the use of levetiracetam in the treatment of PKC. Levetiracetam was effective in eliminating paroxysmal events and should be considered as an alternative to standard antiepileptic medications in this disorder.

Original languageEnglish (US)
Pages (from-to)614-615
Number of pages2
JournalMovement Disorders
Volume17
Issue number3
DOIs
StatePublished - May 1 2002
Externally publishedYes

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis'. Together they form a unique fingerprint.

Cite this